Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Zomedica Pharmaceuticals Q4 Sales $6.20M Inline

Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly sales of $6.20 million which met the analyst consensus estimate. This is a 51.92 percent increase over sales of $4.08 million the same period last year.

byMichael Horton

March 15, 2023

1 minute read

Xenon Pharmaceuticals Prices 3.75M Share Public Offering @$16/Share

By Charles Gross

Today, 11:48 PM

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) today announced the pricing of its underwritten public offering of 3,750,000 common shares pursuant…

XENE

Wells Fargo Maintains Overweight on Olin, Raises Price Target to $60

By Benzinga Newsdesk

Today, 11:48 PM

Wells Fargo analyst Michael Sison maintains Olin (NYSE:OLN) with a Overweight and raises the price target from $56 to $60.

OLN

Trean Insurance Group Q2 Adj. EPS $0.08 Down From $0.09 YoY

By Benzinga Newsdesk

Today, 11:48 PM

Trean Insurance Group (NASDAQ:TIG) reported quarterly earnings of $0.08 per share. This is a 11.11 percent decrease over earnings of $0.09 per share from the same period last year.

TIG